Sue Gao

1.1k total citations
20 papers, 867 citations indexed

About

Sue Gao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Sue Gao has authored 20 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Economics and Econometrics. Recurrent topics in Sue Gao's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers) and Economic and Financial Impacts of Cancer (6 papers). Sue Gao is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers) and Economic and Financial Impacts of Cancer (6 papers). Sue Gao collaborates with scholars based in United States, Netherlands and Sweden. Sue Gao's co-authors include Philip B. Mellen, David C. Goff, Mara Z. Vitolins, Beth Barber, Zhongyun Zhao, Annette L. Fitzpatrick, Shirley A.A. Beresford, Laura L. Frank, Pamela J. Schreiner and Gregory L. Burke and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and Diabetes Care.

In The Last Decade

Sue Gao

20 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sue Gao United States 13 396 194 185 114 113 20 867
Dale S. Hardy United States 18 262 0.7× 162 0.8× 273 1.5× 103 0.9× 36 0.3× 27 995
Mara M. Epstein United States 17 135 0.3× 59 0.3× 272 1.5× 39 0.3× 91 0.8× 61 822
Dirkje W. Sommeijer Netherlands 18 160 0.4× 100 0.5× 358 1.9× 65 0.6× 80 0.7× 56 944
Janise M. Roh United States 19 146 0.4× 176 0.9× 720 3.9× 93 0.8× 34 0.3× 80 1.2k
Mandana Kamgar United States 15 214 0.5× 91 0.5× 263 1.4× 99 0.9× 39 0.3× 51 905
Steven Oliver United Kingdom 19 254 0.6× 59 0.3× 396 2.1× 106 0.9× 18 0.2× 33 1.0k
Michelle Wilson Canada 17 126 0.3× 52 0.3× 210 1.1× 45 0.4× 69 0.6× 62 879
Barbara de Graaff Australia 16 127 0.3× 95 0.5× 51 0.3× 25 0.2× 156 1.4× 63 997
Bettina F. Drake United States 19 265 0.7× 153 0.8× 422 2.3× 37 0.3× 158 1.4× 70 1.3k
Carles Forné Spain 13 147 0.4× 82 0.4× 145 0.8× 29 0.3× 14 0.1× 41 712

Countries citing papers authored by Sue Gao

Since Specialization
Citations

This map shows the geographic impact of Sue Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Gao more than expected).

Fields of papers citing papers by Sue Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Gao. The network helps show where Sue Gao may publish in the future.

Co-authorship network of co-authors of Sue Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Gao. A scholar is included among the top collaborators of Sue Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Gao. Sue Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Sue, et al.. (2012). Tumor hormone/HER2 receptor status and pharmacologic treatment of metastatic breast cancer in Western Europe. Current Medical Research and Opinion. 28(7). 1111–1118. 12 indexed citations
2.
Jones, Clare, et al.. (2012). The impact of infusion reactions associated with monoclonal antibodies in metastatic colorectal cancer: A European perspective. Journal of Oncology Pharmacy Practice. 19(1). 38–47. 6 indexed citations
3.
Burudpakdee, Chakkarin, et al.. (2011). Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies. Journal of Medical Economics. 15(2). 371–377. 17 indexed citations
4.
Zhao, Zhongyun, Elise M. Pelletier, Beth Barber, et al.. (2011). Major Surgery in Patients with Metastatic Colorectal Cancer in Western Europe. Journal of Gastrointestinal Cancer. 43(3). 456–461. 10 indexed citations
5.
Vera‐Llonch, Montserrat, Derek Weycker, Andrew G. Glass, et al.. (2011). Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Services Research. 11(1). 305–305. 41 indexed citations
6.
Overbeek, Jetty A., Zhongyun Zhao, Myrthe P. P. van Herk‐Sukel, et al.. (2011). Costs of hospital events in patients with metastatic colorectal cancer. Journal of Medical Economics. 14(5). 656–661. 6 indexed citations
7.
Vera‐Llonch, Montserrat, Derek Weycker, Andrew G. Glass, et al.. (2011). Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality. BMC Cancer. 11(1). 250–250. 57 indexed citations
8.
Zhao, Zhongyun, Elise M. Pelletier, Beth Barber, et al.. (2011). Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe. Current Medical Research and Opinion. 28(2). 221–229. 28 indexed citations
9.
Song, Xue, Zhongyun Zhao, Beth Barber, et al.. (2011). Characterizing Medical Care by Disease Phase in Metastatic Colorectal Cancer. Journal of Oncology Practice. 7(3S). 25s–30s. 28 indexed citations
10.
Song, Xue, Zhongyun Zhao, Beth Barber, et al.. (2010). Cost of illness in patients with metastatic colorectal cancer. Journal of Medical Economics. 14(1). 1–9. 31 indexed citations
11.
Lage, Maureen J., Rohit Borker, Beth Barber, & Sue Gao. (2010). Healthcare costs in postmenopausal women with hormone-positive metastatic breast cancer. Journal of Medical Economics. 13(4). 691–697. 8 indexed citations
12.
Gao, Sue, Annette L. Fitzpatrick, Bruce M. Psaty, et al.. (2009). Suboptimal Nutritional Intake for Hypertension Control in 4 Ethnic Groups. Archives of Internal Medicine. 169(7). 702–702. 36 indexed citations
13.
Mellen, Philip B., Sue Gao, Mara Z. Vitolins, & David C. Goff. (2008). Deteriorating Dietary Habits Among Adults With Hypertension. Archives of Internal Medicine. 168(3). 308–308. 312 indexed citations
14.
Mathias, Susan D., Sue Gao, Kimberly Litwin Miller, et al.. (2008). Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health and Quality of Life Outcomes. 6(1). 13–13. 81 indexed citations
15.
Gao, Sue, Shirley A.A. Beresford, Laura L. Frank, et al.. (2008). Modifications to the Healthy Eating Index and its ability to predict obesity: the Multi-Ethnic Study of Atherosclerosis. American Journal of Clinical Nutrition. 88(1). 64–69. 115 indexed citations
16.
Mathias, Susan D., Sue Gao, Mark Rutstein, et al.. (2008). Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences. Current Medical Research and Opinion. 25(2). 375–383. 22 indexed citations
17.
Nguyen, Huong Q., Matthew L. Maciejewski, Sue Gao, et al.. (2008). Health Care Use and Costs Associated With Use of a Health Club Membership Benefit in Older Adults with Diabetes. Diabetes Care. 31(8). 1562–1567. 32 indexed citations
18.
George, James N., Roger M. Lyons, Ronald S. Go, et al.. (2007). Health-Related Quality of Life (HRQoL) in Patients (Pts) with Chronic Immune Thrombocytopenic Purpura (ITP): Results from Two Placebo-Controlled Phase 3 Studies of AMG 531.. Blood. 110(11). 1314–1314. 1 indexed citations
19.
20.
Chew, Fiona, et al.. (2006). Can Health Journalists Bridge the State-of-the-Science Gap in Mammography Guidelines?. Science Communication. 27(3). 331–351. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale S. Hardy Breakdown of academic impact, for papers by Mara M. Epstein Breakdown of academic impact, for papers by Dirkje W. Sommeijer Breakdown of academic impact, for papers by Janise M. Roh Breakdown of academic impact, for papers by Mandana Kamgar Breakdown of academic impact, for papers by Steven Oliver Breakdown of academic impact, for papers by Michelle Wilson Breakdown of academic impact, for papers by Barbara de Graaff Breakdown of academic impact, for papers by Bettina F. Drake Breakdown of academic impact, for papers by Carles Forné
Rankless by CCL
2026